Rafael Amado, President, R&D at Adaptimmune Therapeutics PLC (ADAP), sold 11,043 shares at $2.06 ($23K) on 2019-08-06, disclosed to the SEC on 2019-08-07.
Open-market sale of $23k ADAP by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZLAB | SELL | 2026-03-16 | $110K | — | Filing → |
| ZLAB | SELL | 2026-03-05 | $174K | — | Filing → |
| ZLAB | SELL | 2026-01-02 | $188K | — | Filing → |